Thursday, October 17, 2013 10:52:00 AM
ASM Webcast today at 10amPT (1pmET)…
Oct17 10amPT (WEBCAST at 10amPT=1pmET): ANNUAL SHAREHOLDER'S MEETING, Irvine Marriott - http://ir.peregrineinc.com/eventdetail.cfm?eventid=134684
…Proxy:
http://www.sec.gov/Archives/edgar/data/704562/000101968713003336/peregrine_def14a.htm
= = = = = = = = = = = = = = = = = = =Upcoming:
Oct21: “AACR-NCI-EORTC Intl. Conf. on Molecular Targets & Cancer Therapeutics”, Boston http://tinyurl.com/mwm5c25
…Updated data from 1st-line NSCLC IST/UNC/uPitt (Bavi+PEM+Carbo) Ph.1B Trial (n=25)
…Early data (21pts comp. Cycle1), “best unconfirmed responses”=> PR=35%, SD=50% (PD=10%). Also, “2pts have completed > 10 cycles with maintenance Bavi.”
Oct28: IASLC 15th World Conf. on Lung Cancer (Sydney AUS) http://tinyurl.com/lhcl5eu
…IASLC = Intl. Association for the Study of Lung Cancer - see PPHM's 10-15-13 PR on this event: http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=797251
…7:00-8:00am: Industry Supported Symposia - Celgene, Myriad, Boehringer Ingelheim, Peregrine Pharm.
…Symposium supported by Peregrine: “Immune Checkpoints in the Tumor Environment: Novel Targets and the Clinical Promise of Combined Immunotherapies”
Nov12–14: Credit Suisse 2013 Healthcare Conf., Scotsdale http://ir.peregrineinc.com/events.cfm
Dec3-4: 25th Annual Piper Jaffray Healthcare Conf., NYC http://tinyurl.com/32azmpy
Dec8-12/Avid: IBC's Antibody Eng. & Therapeutics, HuntingtonBeach http://www.ibclifesciences.com/antibodyeng
…Dec11: Kerry Chester (UK Researcher) to make tribute to Dr. Phil Thorpe (1951-2013) in her chairperson’s remarks, followed by UTSW’s Dr. Sally Ward as 1st speaker in track, “Antibodies In A Complex Environment” – she was co-recipient with Drs. Thorpe/Mason/Ober of a $6.0mm 3-2011 grant from Texas’s CPRIT - see http://tinyurl.com/k6wlabk
~Dec9: FY'14/Q2 (q/e 10-31-13) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Jan28-30'14/Avid/Table#19: “18th CASSS WCBP Symposium”, WashDC https://m360.casss.org/event.aspx?eventID=72301
…“18th Symposium on the Interface of Regulatory & Analytical Sciences for Biotechnology Health Products”
…CASSS = “The California Separation Science Society” (4000 members); WCBP = "Well Characterized Biotechnology Pharmaceutical"
Mar12’14: ECCO’s 1st Immunotherapy of Cancer Conf., Munich http://www.ecco-org.eu/Events/ITOC1.aspx & http://tinyurl.com/lr6r23e
…ECCO = European CanCer Organization
…3-12-14 4:30pm Plenary/Cancer Immunology: “Bavituximab: A Novel PS-Targeting Immunotherapy for the Treatment of Cancer”, Joe Shan (Peregrine Pharm.)
Oct17 10amPT (WEBCAST at 10amPT=1pmET): ANNUAL SHAREHOLDER'S MEETING, Irvine Marriott - http://ir.peregrineinc.com/eventdetail.cfm?eventid=134684
…Proxy:
http://www.sec.gov/Archives/edgar/data/704562/000101968713003336/peregrine_def14a.htm
= = = = = = = = = = = = = = = = = = =Upcoming:
Oct21: “AACR-NCI-EORTC Intl. Conf. on Molecular Targets & Cancer Therapeutics”, Boston http://tinyurl.com/mwm5c25
…Updated data from 1st-line NSCLC IST/UNC/uPitt (Bavi+PEM+Carbo) Ph.1B Trial (n=25)
…Early data (21pts comp. Cycle1), “best unconfirmed responses”=> PR=35%, SD=50% (PD=10%). Also, “2pts have completed > 10 cycles with maintenance Bavi.”
Oct28: IASLC 15th World Conf. on Lung Cancer (Sydney AUS) http://tinyurl.com/lhcl5eu
…IASLC = Intl. Association for the Study of Lung Cancer - see PPHM's 10-15-13 PR on this event: http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=797251
…7:00-8:00am: Industry Supported Symposia - Celgene, Myriad, Boehringer Ingelheim, Peregrine Pharm.
…Symposium supported by Peregrine: “Immune Checkpoints in the Tumor Environment: Novel Targets and the Clinical Promise of Combined Immunotherapies”
Nov12–14: Credit Suisse 2013 Healthcare Conf., Scotsdale http://ir.peregrineinc.com/events.cfm
Dec3-4: 25th Annual Piper Jaffray Healthcare Conf., NYC http://tinyurl.com/32azmpy
Dec8-12/Avid: IBC's Antibody Eng. & Therapeutics, HuntingtonBeach http://www.ibclifesciences.com/antibodyeng
…Dec11: Kerry Chester (UK Researcher) to make tribute to Dr. Phil Thorpe (1951-2013) in her chairperson’s remarks, followed by UTSW’s Dr. Sally Ward as 1st speaker in track, “Antibodies In A Complex Environment” – she was co-recipient with Drs. Thorpe/Mason/Ober of a $6.0mm 3-2011 grant from Texas’s CPRIT - see http://tinyurl.com/k6wlabk
~Dec9: FY'14/Q2 (q/e 10-31-13) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Jan28-30'14/Avid/Table#19: “18th CASSS WCBP Symposium”, WashDC https://m360.casss.org/event.aspx?eventID=72301
…“18th Symposium on the Interface of Regulatory & Analytical Sciences for Biotechnology Health Products”
…CASSS = “The California Separation Science Society” (4000 members); WCBP = "Well Characterized Biotechnology Pharmaceutical"
Mar12’14: ECCO’s 1st Immunotherapy of Cancer Conf., Munich http://www.ecco-org.eu/Events/ITOC1.aspx & http://tinyurl.com/lr6r23e
…ECCO = European CanCer Organization
…3-12-14 4:30pm Plenary/Cancer Immunology: “Bavituximab: A Novel PS-Targeting Immunotherapy for the Treatment of Cancer”, Joe Shan (Peregrine Pharm.)
